Some points to (re)consider here
1. Attenuation MYC+ 6w->12w: we might have a word for it: convergence, but don't have a why? Most important in this is the mito part: whne you do the fgsea per category analysis the mitocarta NES is calculated for all the pathways together (I guess?). However, we had previous fGSEA results on individual pathways - see folder `fgsea` where we see that NES of important pathways - OXPHOS!! and subunits, chaperones, protein import - are actually have negative NES. Is this something that can be linked to the imbalance and Myc specific biogenesis? Results whihc go into figures, whould be more detailed here, the category average for fGSEA is important but not enough, we need to see details.
2. WHere do we stand with the different biogenesis pathways? I still don't see a conclusion on the differences between MYc induced and ER induced biogenesis, also here TFs and interaction gene sets etc has to be interpreted in detail.
3. Where do we stand with the impact of MYc on development - changing trajectory chaging cell composition - sould this be the actual reason for the death-timing explanations?
4. I really liked the interpreations of script 22 and 23, these bring more clarity and novel hypotheses - but I have the following questions to what you have concluded there: (your conclusions quoted, in betwwen my questions)

> Script 23 in itself
> 
>   H1 — Myc engages the death program at 6W, and that engagement fades (the powered spine)
> 
>   My prior framing was "the WT substrate de-primes with age." The data refute that — WT baseline priming is flat-to-slightly-rising (6W_neg −0.236 → 12W_neg
>   −0.082). The real signal is not in the WT baseline; it's in Myc's coupling to the death program:
>   
>   - Myc raises pro-apoptotic priming, powered: priming (PRO−ANTI) genotype main effect +0.317, p=0.038; and on the Myc-at-6W contrast the PRO module is
>   coordinately up (+0.196, p=0.041). This is oncogene-induced apoptotic priming, visible even under survivor bias (which is conservative — the cells that
>   already died aren't sequenced, so the true engagement is higher than measured).
>   - It's ~3× stronger at 6W than 12W: the Myc-induced priming gap is +0.48 at 6W vs +0.15 at 12W (group means). The attenuation shows in the interaction
>   (state int_beta −0.327) and lands on Gate 2 (PRO module interaction LFC −0.130, t p=0.023, DECISION_POINT) and branch-2 (apoptosis modality temporal_pos
>   NES −1.38, padj 0.016 — the death program declines in Myc+ with age).
>   - p53/ARF is essentially null (p53 composite flat; only the 4-gene ARF core hints at a WT decline, arf LFC −0.179). Do not build a p53 story — the rheostat
>   is BCL2-family, not p53.
> 
>   So H1 reframes to: Myc's death-coupling is substrate-gated — it engages pro-apoptotic priming strongly at 6W and weakly at 12W — not "the tissue is
>   intrinsically death-resistant at 12W."

*HERE THE QUESTION IS WHY???? - I GUESS WE ARE DELAING WITH A DIFFERENT POPULATION OF CELLS, BUT THAT DIFFERENT POPULATION IS THE PRODUCT OF NORMAL DEVELOPMENT SINCE WE SEE IT IN THE MYC-ER EXPERIMENT!!!!!*


> H2 — the mechanism: mitonuclear imbalance, and it's a 6W-specific coupling (the standout)
>   
>   This is the strongest, cleanest part, and it vindicates pulling the script-22 reprioritisation finding in here:
>   
>   - Mitonuclear imbalance peaks exactly at 6W_pos (+0.499), vs 6W_neg +0.13, 12W_pos −0.17, 12W_neg −0.46. Myc at 6W drives nuclear OXPHOS up while
>   mtDNA-encoded stays low (0.55) → the biggest nuclear/mtDNA mismatch in the cohort, in the death-permissive group.
>   - That imbalance is coupled to death priming at 6W and the coupling vanishes by 12W: imbalance ~ PRO r 0.75 (p=0.005) at 6W → 0.07 (p=0.82) at 12W.
>   Biogenesis~death does the same (0.77→0.56), intersections~death (0.81→0.69).
>   - The mitoPPS lens adds the reprioritisation nuance (same two-lens split as AP-abund): at 6W Myc absolutely raises PRO expression (+0.196) but relatively
>   de-prioritises Apoptosis-PRO within the mito compartment (diff −0.21, padj 0.022) — because it raises biogenesis even harder. Death priming rises;
>   biogenesis crowds it out of the mito resource budget. That squeeze is the imbalance.


*this is to rethink - I think the change from 6W -> 12W mtDNA encoded going up selectively is not built into this interpretation???*


> H3 — proliferation coupling does not explain the timing
> 
>   prolif ~ PRO is r 0.68→0.65 — coupled at both timepoints, essentially invariant. So the 6W-specific death coupling is not generic proliferation; it's
>   specifically the mito/biogenesis-imbalance arm (H2). This sharpens rather than dilutes the story.
>   
>   H4 — survivor CV: mild, on-narrative
>   
>   cv_PRO: Myc+ 0.017→0.007 (narrows ~57%, more than WT's 0.012→0.008); 6W_pos is the most heterogeneous group. Weakly consistent with sensitive-cell culling
>   → converged 12W survivors. The cv_death composite is muddier. Suggestive only — the weakest arm, as flagged.


*this should anyway be used, there MUST be selective culling, and there MUST be chage in cell composition, this is why we did the gsva scoring, and actually there is something there*

The model this assembles
  
  Not "old tissue resists death," but: Myc's death-coupling is substrate-gated through mitochondrial state. At 6W, Myc forces a mitonuclear-imbalanced, 
  selectively-reprioritised biogenesis state that is tightly coupled to pro-apoptotic priming (oncogene-induced apoptosis). By 12W, biogenesis is 
  uniform/balanced (script 22) and decoupled from death (r 0.75→0.07), and Myc's pro-death drive has faded (Gate 2). The decoupling is the loss of killing.
  Powered anchors: Myc raises priming (p=0.038/0.041) and Gate 2 attenuation (p=0.023); the coupling correlations are striking within-timepoint (n=12)
  directional support, survivor-biased and uncorrected.

*but the question still remains - why the mitochondrial state changes? is it developmental????*

> In the Block A context
> 
>   This lands better than "contingent." Three shifts to the review:
> 
>   1. Narrative D (cell-death / mito-decision-point) is no longer just Tier-2 directional. It now has a powered anchor (Myc pro-death priming p=0.038; Gate 2
>   p=0.023) plus a mechanistic mito bridge (the mitonuclear-imbalance coupling, 0.75→0.07). It also connects A and D: the same preferential-mito amplification
>   (AP6.2) that defines the Myc footprint produces, at 6W, the imbalanced state that gates death. "Mitochondria integrate oncogenic and metabolic programs to
>   shape progression" — this is the integration, made mechanistic.

*good*

>   2. It resolves the biogenesis-death-coupling thread. The earlier guess was "Myc biogenesis is uncoupled from death (unlike ER/PGC1α)." The data say Myc
>   biogenesis starts coupled (6W, r 0.77) and becomes uncoupled (12W). Myc's uncoupling is an adaptation over the window, not a constitutive property — and
>   that adaptation is the loss of killing. Matches the companion Menegollo/Bentham mito-decision-point theme.

*where does it land on the experimental result that ER/PGC1a kills??*

>   2. It reshapes open decision #2 (cell death main vs supp). The death story now has a real mechanistic spine, so I'd argue for a strong Supp with a 
>   main-figure hook: the mitonuclear-imbalance-peaks-at-6W_pos panel (H2) is a clean, powered-adjacent figure that ties the mito thesis (Fig 1) to the death
>   phenotype.
> 
>   One honesty correction to carry forward: the death-timing memory said "anchor on WT substrate de-priming with age" — that specific mechanism is refuted;
>   the substrate-gating acts on Myc's coupling, not the WT baseline. I'll fix that in memory.

*so we have to throw out the idea that the background changes drive the difference???? But something has to change in the backgroun to change Myc- coupling???*